Subsequently, the team demonstrated that 6A10, similarly to CA XII small molecule inhibitors, acts to indirectly reduce Pgp activity when applied to CA XII+ve/Pgp+ve drug resistant cancer cells[77]. The gene discussed is CA12; the disease is cancer.